Dilution- Warrants16 Feb 2022 12:47
Lock in ending. Circa 10% dilution if fully exercised.
504,750,000 Shares
52,960,000 warrants (24,000,000 to directors)
Subsequent events
On 28 October 2021, the Company granted options over a total of 700,000 ordinary shares of
GBP0.001 each. Jodie Sanders, commercial and partnerships director, and Sean O'Dwyer, marketing director, who joined the Company in August and September 2021 respectively, were each granted options over 250,000 ordinary shares. Antony Buck, a skincare adviser, was granted options over 200,000 ordinary shares, this follows an announcement on 6 May 2021, that he would be granted warrants over 200,000 ordinary shares in July 2021; these warrants were never issued.
The exercise price of the two sets of 250,000 options is 7.06 pence per share, with a total exercise period of ten years, and the options can be exercised in stages starting from the fourth quarter of 2022 to the fourth quarter of 2023.
The options over 200,000 ordinary shares can be exercised at 7.812 pence per share, from 12 July 2022, and will lapse on 12 July 2024 if not exercised.